Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.000001 per share
-
Shares outstanding
-
139,295,316
-
Total 13F shares
-
82,710,575
-
Share change
-
+8,208,479
-
Total reported value
-
$134,818,000
-
Price per share
-
$1.63
-
Number of holders
-
14
-
Value change
-
+$13,336,837
-
Number of buys
-
6
-
Number of sells
-
9
Institutional Holders of Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share (XTNT) as of Q2 2021
As of 30 Jun 2021 Xtant Medical Holdings, Inc. - Common Stock, par value $0.000001 per share (XTNT) had 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 82,710,575 shares of stock of the company.
Largest 10 holders included ORBIMED ADVISORS LLC, Altium Capital Management LP, RENAISSANCE TECHNOLOGIES LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, Virtu Financial LLC, CITADEL ADVISORS LLC, BlackRock Inc., STATE STREET CORP, and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 14 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.